.jpg)
.png)
Fall 2019
Discuss this article at www.lipid.org/lipidspin “I have never once dribbled the whole field and scored a goal by myself.” — Abby Wambach (retired US Women’s Soccer great) I am honored to have the unique opportunity to address LipidSpin readers as both its co-editor and guest editor (outgoing... more
Discuss this article at www.lipid.org/lipidspin It has been more than 30 years since the first National Cholesterol Education Program (NCEP) lipid treatment guideline was published in January 1988 in the Archives of Internal Medicine.(1) At the time, few clinical practice guidelines existed.... more
Discuss this article at www.lipid.org/lipidspin Diabetes mellitus (DM) is a leading cause of cardiovascular disease (CVD) and its associated morbidity and mortality.(1) DM confers the highest lifetime risk of any individual risk factor for developing cardiovascular disease. Although morbidity... more
Discuss this article at www.lipid.org/lipidspan Cardiovascular risk stratification is imperfect. There are multiple formulas with receiver operator curve (ROC) values, a measure of discrimination between predicted events and nonevents varying from 0.7 to 0.8. There are multiple risk scores. The... more
Discuss the article at www.lipid.org/lipidspin Both genetic and observational studies have shown that elevated triglycerides (TG) are a marker of increased cardiovascular (CV) risk, even in statin-treated patients. (1) However, randomized clinical trials with TG-lowering drugs such as fibrates,... more
Discuss this article at www.lipid.org/lipidspin Clinical practice guidelines are integral to daily management of cardiovascular diseases, including hyperlipidemia. The most recent 2018 Multisociety Cholesterol Guidelines advocate for a more personalized approach to risk assessment.... more
Loretta is a 60-year-old white woman with a past medical history significant for hypercholesterolemia, mitral regurgitation, hypertension, pregnancy-induced hypertension (twice) and a family history of premature coronary heart disease (her father had myocardial infarction at age 53). Recent... more
In October 2018, the American College of Cardiology (ACC) and the American Heart Association (AHA), in collaboration with the National Lipid Association and other organizations, published evidencebased guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease... more
Cardiovascular disease (CVD) remains the leading cause of death for women in the United States.(1) Unique factors affecting a woman’s health contribute significantly to CVD risk, but historically were not always represented in major guidelines. Some of these factors include hormonal changes, the... more
A primary mission of the National Lipid Association (NLA) is to invigorate interest in lipidology-based prevention strategies amongst the healthcare community and the public at-large. Through diverse leadership direction and innovation, the Northeast Lipid Association (NELA) is having a successful... more